Prenetics logo

Head of Internal Audit

Prenetics

New York, NYOnsitePosted 4 days ago
Full TimeDirector & AboveCorporate FunctionsDiagnostics
Original posting ↗

Summary

We are looking for a hands-on Head of Internal Audit to build and lead the function and the ongoing SOX program. You will support management's annual ICFR assessment under SOX 404(a) and prepare for the company's first external auditor attestation under SOX 404(b), targeting the year ending December 31, 2027.

Job description

Position Overview

We are looking for a hands-on Head of Internal Audit to build and lead the function and the ongoing SOX program. You will support management's annual ICFR assessment under SOX 404(a) and prepare for the company's first external auditor attestation under SOX 404(b), targeting the year ending December 31, 2027.

You will personally perform walkthroughs, testing and documentation while directing a co-sourced testing provider, advising process owners on remediation and independently validating closure. The role reports functionally to the Audit Committee and administratively to the Group CFO. Travel of approximately 25-35%, including recurring international trips to Hong Kong, is a firm requirement.

Key Responsibilities

  • Establish the function: develop the Internal Audit Charter, operating model and independence framework in accordance with the IIA Global Internal Audit Standards and present them to the Audit Committee for approval.
  • Maintain independence and objectivity: provide impartial, risk-based assurance over governance, risk management and internal controls.
  • Lead SOX compliance and readiness: lead ICFR risk assessment, scoping, documentation standards, design and operating-effectiveness testing, deficiency evaluation and reporting to support management's annual SOX 404(a) assessment and preparation for external auditor attestation under SOX 404(b).
  • Assess IT controls: evaluate the design and operating effectiveness of IT general controls (ITGCs), automated application controls, system interfaces and reports supporting financial reporting.
  • Manage co-source providers: select, scope and oversee co-sourced SOX and specialist audit providers, manage budgets, delivery timelines and workpaper quality.
  • Oversee remediation and transition risks: identify root causes, assign accountable owners, agree remediation deadlines, retest controls and escalate overdue high-risk findings.
  • Develop and execute the risk-based audit plan: assess enterprise risk annually and maintain an Audit Committee-approved plan covering ICFR, operational, compliance and IT/cyber risk.
  • Coordinate with external auditors: align on scope, testing approach, timing and evidence requirements to support potential reliance on Internal Audit's work.
  • Report to the Audit Committee: charter, plan, results, remediation status and executive sessions each quarter.
  • Partner with cross-functional teams: build relationships with Finance, IT, Operations, Marketing, People Operations and other process owners.
  • Be hands-on: draft workpapers, perform testing and build documentation personally during the build phase.
  • Monitor the environment: track SEC, PCAOB and internal-control developments relevant to a NASDAQ issuer approaching 404(b).
  • Use modern tooling: apply data analytics, automation and AI-enabled approaches to increase audit coverage and efficiency.

Requirements

  • 10+ years of progressive internal audit / external audit / risk experience, including at least three years leading a public-company SOX program or internal audit function.
  • CPA or CIA required.
  • Demonstrated experience leading SOX 404(a) assessment and testing program at a public company, with strong knowledge of COSO, relevant SEC/PCAOB requirements, IT general controls, automated controls, and the completeness and accuracy of reports used in controls.
  • Direct Audit Committee exposure: you have presented plans, results and deficiencies to a committee before.
  • Willingness to travel ~25-35%, including international travel to Hong Kong on a recurring basis.
  • Comfort operating as a senior individual contributor: credibility without an org chart, sound independent judgment and confidence escalating significant issues.

Nice to Have

  • Experience standing up or substantially rebuilding an Internal Audit function.
  • Experience preparing a company for first-time SOX 404(b) attestation.
  • A Big 4 or top-tier national firm foundation.
  • CISA certification in addition to CPA or CIA.

You Must Be AI-Native

Active, fluent daily AI tool usage is mandatory, not optional. We expect you to be embedding AI into your day-to-day workflows from day one. Use approved AI tools, data analytics and automation to expand audit coverage, identify exceptions and improve documentation and testing efficiency.

Requirements

  • 10+ years of progressive internal audit / external audit / risk experience
  • At least three years leading a public-company SOX program or internal audit function
  • CPA or CIA required
  • Demonstrated experience leading SOX 404(a) assessment and testing program at a public company
  • Strong knowledge of COSO, relevant SEC/PCAOB requirements, IT general controls, automated controls, and completeness and accuracy of reports used in controls
  • Direct Audit Committee exposure: presented plans, results and deficiencies to a committee
  • Willingness to travel ~25-35%, including international travel to Hong Kong on a recurring basis
  • Comfort operating as a senior individual contributor with sound independent judgment and confidence escalating significant issues
  • Active, fluent daily AI tool usage is mandatory

Company overview

Prenetics Global Limited is a Hong Kong-based health sciences company that operates at the intersection of biotechnology, diagnostics, and consumer health. Founded in 2014 by serial entrepreneur Danny Yeung, the company has established itself as a leading player in diagnostic and genetic testing services. Prenetics gained significant recognition during the COVID-19 pandemic by conducting over 5 million tests for clients including the Hong Kong government and London Heathrow Airport. The company went public on NASDAQ in 2022 through a SPAC merger valued at $1.7 billion, becoming the first Hong Kong unicorn to become publicly traded. Prenetics operates through multiple business units including IM8 for health and wellness products, CircleDNA for consumer genetic testing using next-generation sequencing technology, ACT Genomics for FDA-cleared genomic profiling of solid tumors, and Insighta for multi-cancer early detection technologies. With operations spanning 10 countries and strategic investors including Alibaba, Ping An, and Prudential, Prenetics has demonstrated remarkable growth, projecting revenue to reach $600 million by 2025. The company positions itself as a comprehensive health sciences platform that combines genomics, diagnostics, and digital health tools to empower consumers with personalized health data while providing healthcare providers with valuable diagnostic insights.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.